Julia Lopez MP: written questions
4 Jul 2025–3 Jul 2026
How these years work
Our reporting years run from 4 July to 3 July, starting with the 2024 general election. They are not official parliamentary sessions. Office costs keep IPSA’s April–March financial years. Records may cover only part of a year; a missing record does not mean no work was done.
Written questions: dates and coverage
- Source checked
- 15 Nov 2026
- Last successful import
- 15 Nov 2026
- Records dated through
- 13 Nov 2026
- Selected period
- Reporting year 2: 4 Jul 2025 to 3 Jul 2026
- Completeness
- Published snapshot: 23,625 records in the source window 17 Aug 2026 to 15 Nov 2026. The published snapshot covers its stated source window. Answers and corrections can appear later; no indexed answer does not prove that none exists.
Understand written questions, dates and answers.
Read what this MP said, asked and contributed in Parliament.
10 published records · newest first.
Written questions
Drugs: VATTreasuryTabled 4 Feb 2026AnsweredUIN 110861More
Question: To ask the Chancellor of the Exchequer, whether her Department has directed HMRC to review the application of VAT upon medicines supplied free-of-charge via EAMS and other compassionate access schemes.
Answer: VAT is the UK’s second largest tax, forecast to raise £180 billion in 2025/26. Taxation is a vital source of revenue which helps to fund public services. The Early Access to Medicines Scheme (EAMS) allows patients access to free medicines for life threate...
Answered 9 Feb 2026
Original Parliament recordInternet: OutagesTreasuryTabled 25 Nov 2025AnsweredUIN 94366More
Question: To ask the Chancellor of the Exchequer, what estimate her Department has made of the cost to the economy of recent outages of large-scale cloud providers.
Answer: I refer the member to the answer given to UIN 92928 on 24 November 2025.
Answered 1 Dec 2025
Original Parliament recordDrugs: VATTreasuryTabled 3 Nov 2025AnsweredUIN 87680More
Question: To ask the Chancellor of the Exchequer, whether she has made an assessment of the potential impact of introducing VAT to to medicines provided free under Early Access Medicines Scheme programmes on pharmaceutical companies.
Answer: I refer the honourable member to the answer that I gave to PQ UIN: 87051.
Answered 11 Nov 2025
Original Parliament recordDrugs: VATTreasuryTabled 31 Oct 2025AnsweredUIN 87052More
Question: To ask the Chancellor of the Exchequer, what assessment her (a) Department and (b) HMRC have conducted on the potential impact on clinical trial numbers from the introduction of VAT to medicines provided free under Early Access Medicines Scheme programmes
Answer: VAT is the UK’s second largest tax, forecast to raise £180 billion in 2025/26. Taxation is a vital source of revenue which helps to fund public services. Early Access to Medicines Scheme (EAMS) allows patients access to free medicines for life threatening...
Answered 5 Nov 2025
Original Parliament recordDrugs: VATTreasuryTabled 31 Oct 2025AnsweredUIN 87051More
Question: To ask the Chancellor of the Exchequer, what assessment (a) her Department and (b) HMRC have conducted on the potential impact on patient access to innovative medicines from the introduction of VAT to medicines provided free under Early Access Medicines S
Answer: VAT is the UK’s second largest tax, forecast to raise £180 billion in 2025/26. Taxation is a vital source of revenue which helps to fund public services. Early Access to Medicines Scheme (EAMS) allows patients access to free medicines for life threatening...
Answered 5 Nov 2025
Original Parliament recordBusiness: InvestmentTreasuryTabled 27 Oct 2025AnsweredUIN 85287More
Question: To ask the Chancellor of the Exchequer, whether she plans to expand the (a) Enterprise Investment Scheme and (b) Seed Enterprise Investment Scheme scheme to support older companies seeking increased investment.
Answer: The Government is focused on making the UK the best place in the world to start and grow a business, and understands the key role of a competitive investment environment in achieving economic growth. At Autumn Budget 2024, the Government committed to crea...
Answered 4 Nov 2025
Original Parliament recordBusiness: InvestmentTreasuryTabled 27 Oct 2025AnsweredUIN 85286More
Question: To ask the Chancellor of the Exchequer, what assessment her Department has made of the potential merits of reforming the (a) Enterprise Investment Scheme and (b) Seed Enterprise Investment Scheme to improve support for firms in the post-start-up phase.
Answer: The Government is focused on making the UK the best place in the world to start and grow a business, and understands the key role of a competitive investment environment in achieving economic growth. At Autumn Budget 2024, the Government committed to crea...
Answered 4 Nov 2025
Original Parliament recordDrugs: VATTreasuryTabled 23 Oct 2025AnsweredUIN 84783More
Question: To ask the Chancellor of the Exchequer, if she will take steps with HM Revenue and Customs to help ensure that a(a) medicines and (b) treatments provided under the Early Access to Medicines Scheme are not subjected to (i) direct or (ii) indirect VAT.
Answer: VAT is the UK’s second largest tax, forecast to raise £180 billion in 2025/26. Taxation is a vital source of revenue which helps to fund public services. Early Access to Medicines Scheme (EAMS) allows patients access to free medicines for life threatening...
Answered 29 Oct 2025
Original Parliament recordDrugs: VATTreasuryTabled 23 Oct 2025AnsweredUIN 84781More
Question: To ask the Chancellor of the Exchequer, if she will commission guidance from HM Revenue and Customs clarifying whether medicines supplied under the Early Access Medicines Scheme fall outside the scope of VAT Deemed Supply rules.
Answer: Under UK VAT law, some transactions where no money changes hands are treated as if a supply has been made – these are called deemed supplies. This is to keep the system fair if a business has reclaimed VAT on costs (like making or importing goods), it sho...
Answered 29 Oct 2025
Original Parliament recordDrugs: VATTreasuryTabled 23 Oct 2025AnsweredUIN 84780More
Question: To ask the Chancellor of the Exchequer, whether medicines provided free under Early Access Medicines Scheme programmes are liable for output VAT.
Answer: Early Access to Medicines Scheme (EAMS) allows patients access to free medicines for life threatening conditions before receiving full NHS approval. There are special VAT rules for the supply of goods without payment. Whether VAT applies will depend on th...
Answered 29 Oct 2025
Original Parliament record
Explore activity by topic or department
Written questions by answering department
4 Jul 2025–3 Jul 2026. One record per UIN and tabled date; the named department is not a measure of answer quality.
View as listWhat this shows and doesn't show
Published records only — not a full account of an MP’s work. How we work →